Lianru Zhang

1.9k citations
35 papers · 1.1k indexed · h-index 17

Lianru Zhang

33 papers receiving 1.1k citations

Peers

Lianru Zhang
Comparison fields: 5 of 95
  • Immunology 267
  • Biomaterials 164
  • Business and International Management 24
  • Oncology 295
  • Molecular Biology 634
Replace Anabel Sorolla with:
Anabel Sorolla Spain
Deepak B. Thimiri Govinda Raj Norway
Yichao Lu China
Suman K. Vodnala United States
Michael Lammers Germany
Matin Chehelgerdi Iran
Masayuki Kohno Japan
William Avery United States
Heesun Cheong South Korea
Lianru Zhang relative to Anabel Sorolla Spain Anabel Sorolla's profile →
Citations per field
00.5×
Anabel Sorolla · 1×
Citations per year

Countries citing papers authored by Lianru Zhang

Since Specialization
Citations

This map shows the geographic impact of Lianru Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianru Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianru Zhang more than expected).

Fields of papers citing papers by Lianru Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianru Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianru Zhang. The network helps show where Lianru Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lianru Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lianru Zhang Line = papers co-authored together Lianru Zhang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20237
2 202240
3 202212
4 20201
5 201911
6 201994
7 201876
8 201724
9 201721
10 2017117
11 201465
12 20149
13 201216
14 201129
15 201089
16
Study on a Screening Model for Inhibitor of Hsp90 ATPase Activity
20106
17 201045
18
Study on Bioactivity of Endophytic Fungi from Ephedra
20081
19
Study on Antioxidant Activity of Marine Fungi
20071
20
Review of development in ephedta^s chemical researching and using
20001

About Lianru Zhang

Lianru Zhang is a scholar working on Toxicology, Immunology and Pharmacology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Heat shock proteins research (10 papers), Immunotherapy and Immune Responses (7 papers), ATP Synthase and ATPases Research (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Computational Drug Discovery Methods (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Immunology (267 citations), Biomaterials (164 citations) and Business and International Management (24 citations). Lianru Zhang has collaborated with scholars based in China. Frequent co-authors include Baorui Liu, Huizi Sha, Shu Su, Fangjun Chen, Fanyan Meng, Jie Shao, Lixia Yu, Hanqing Qian, Zhengyun Zou and Rutian Li. Their work appears in journals such as Nature Communications, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026